VASCULAR ulcers and wounds TecarEvolution

Product catalog summary

Introduction
Non-ablative radiofrequency, specifically Tecar therapy, is emerging as a promising treatment for ulcers and wounds, particularly in cases where traditional methods have been ineffective. This document introduces the TecarEvolution devices developed by Capenergy, which utilize medium wave RF diathermy to accelerate wound healing.

Specifications
The TecarEvolution devices are designed for treating various conditions such as pressure ulcers, vascular ulcers, skin lesions, diabetic foot, venous disorders, and peripheral neuropathies. The devices operate at three frequencies (0.8 MHz, 1 MHz, and 1.2 MHz) with a power output of 310W and include features like temperature control and biofeedback. The C-Boot accessory is included for enhanced application.

Procedures
The treatment involves manual capacitive and resistive applications for tissues with different water content, as well as an automatic application for localized ulcers. The process is automated for efficiency and safety, requiring minimal training for operators.

Clinical Results
Clinical studies have shown significant improvements in healing times. For instance, the C-100 Vascular device, used with the C-Boot, resolved 100% of long-evolution ulcers within six weeks, with one session per week. The C-200 device improved healing by 60% over two months with weekly sessions.

Regulatory Compliance
The devices comply with European regulations as medical devices, certified by Notified Body CE 1639 under Directive 93/42/EEC. They meet the standards for medical electrical equipment safety and electromagnetic compatibility.

Conclusion
The TecarEvolution devices represent a significant advancement in the treatment of ulcers and wounds, offering a faster, safer, and more effective alternative to traditional methods.

Catalog excerpts

VASCULAR ulcers and wounds TecarEvolution-1

A new perspective for the treatment of ulcers Non-ablative Radiofrequency for ulcers and wounds TecarEvolution The treatment of ulcers, as well as other injuries of difficult evolution has been done until now with intervention systems that offer little to no results. The negative pressure techniques, antibiotic treatments or hyperbaric chambers, among others, have not offered a deﬁnitive solution to this problem suffered by elderly people, diabetics or other groups affected by processes of epithelialisation. Non-ablative diathermy by conducted medium wave RF, also known as Tecar therapy because of its acronym for Capacitive and Resistive Energy Transfer), is a widely used device in the ﬁeld of musculoskeletal physiotherapy that is now evolving into the ﬁeld of injuries and ulcers. Automatic application by means of the C-Boot The 2 Generation devices developed by Capenergy, equip the inﬁrmary with a new instrument that has proven to effectively close this kind of wounds in a third of the conventional treatment time. Through a temperature control system, the device stimulates blood circulation thanks to its endogenous effect of mobilizing ﬂuids and it generates the necessary growth factors for the wound to close. • Vascular ulcers • Diabetic foot • Venous disorders • Peripheral Neuropathies European regulation: Medical Device. Notified Body CE 1639. Directive 93/42/EEC. EN 60601-1:2008 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance. EN 60601-1-2:2008 - Medical electrical equipment - Part 1-2: General requirements for basic and essential performance - Collateral standard: electromagnetic compatibility - Requirements and tests. • Skin lesions Thanks to its temperature control system, Capenergy can automate the process so the session is fast, effective, safe and easy to perform by an operator after a simple training. • Pressure ulcers Tríptico Profesionales úlceras y heridas 2022 | V.1 |In

Open the catalog to page 1

VASCULAR ulcers and wounds TecarEvolution-2

Second Generation TecarEvolution Devices C-100 Vascular with C-Boot solves 100% of ulcers of long evolution within a month and a half.* An ulcer is considered of long evolution after more than 2 years. The treatment time is 6 weeks with one weekly session as treatment protocol. * Delgado H.R, Rodriguez L J. Treatment of Diabetic Foot Ulceras Using Technology with A C-Boot Device. Acta Scientiﬁc Medical Sciences 4.2 (2020): 01-07. DOI: 10.31080/ASMS.2020.04.treatment-of-diabetic-foot-ulceras- using-technology- with-a-c-boot-device Tecar Specialty C-100 Vascular Tecar Therapy boot to introduce...

Open the catalog to page 2

VASCULAR ulcers and wounds TecarEvolution

VASCULAR ulcers and wounds TecarEvolution

Catalog excerpts

Archived catalogs